Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 12-2018 | 06-2018 | 12-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,525 | 2,319 | 4,254 | 5,830 | 8,284 |
| Receivables | 586 | 345 | 234 | 270 | 321 |
| Other current assets | 175 | 214 | 157 | 220 | 164 |
| TOTAL | $2,286 | $2,878 | $4,645 | $6,320 | $8,769 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,335 | $2,951 | $4,780 | $6,570 | $9,128 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 719 | 432 | 733 | 480 | 677 |
| Other current liabilities | 349 | 289 | 392 | 420 | 428 |
| TOTAL | $1,068 | $721 | $1,125 | $900 | $1,105 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1 | 66 | 3 | 20 | 48 |
| TOTAL | $1 | $66 | $3 | $20 | $48 |
| Total Liabilities | $1,068 | $786 | $1,127 | $930 | $1,153 |
| Shareholders' Equity | |||||
| Retained earnings | -92,788 | -90,641 | -95,604 | -93,160 | -88,846 |
| Other shareholders' equity | 94,055 | 92,805 | 99,257 | 98,790 | 96,822 |
| TOTAL | $1,267 | $2,164 | $3,653 | $5,630 | $7,976 |
| Total Liabilities And Equity | $2,335 | $2,950 | $4,780 | $6,560 | $9,129 |